Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

TAT 2019 – International Congress on Targeted Anticancer Therapies

The home of phase 1 oncology

Start date: 25 Feb 2019
End date: 27 Feb 2019
Location: Paris, France

The TAT congress is the premier forum for discussion of early phase drug development and translational research.

Leaders from academia and industry, clinicians, researchers and regulators work together to speed up the development of new anti-cancer treatments for better patient outcomes.

The TAT Congress series has been at the forefront of revolutionary transformation in early drug development and has succeeded in broadening the conversation on phase I trials to include a wide circle of stakeholders.

TAT 2019 put its participants at the heart of discussions shaping the most promising paths for developing new therapeutics. It provided the opportunity to shape the future of drug development together with the world’s most renowned experts.

We hope to see you at the next edition!